Pharmacogenetic evaluation of ABCB1, Cyp2C9, Cyp2C19 and methylene tetrahydrofolate reductase polymorphisms in teratogenicity of anti-epileptic drugs in women with epilepsy
about
Pharmacogenetic evaluation of ABCB1, Cyp2C9, Cyp2C19 and methylene tetrahydrofolate reductase polymorphisms in teratogenicity of anti-epileptic drugs in women with epilepsy
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pharmacogenetic evaluation of ...... c drugs in women with epilepsy
@ast
Pharmacogenetic evaluation of ...... c drugs in women with epilepsy
@en
Pharmacogenetic evaluation of ...... c drugs in women with epilepsy
@nl
type
label
Pharmacogenetic evaluation of ...... c drugs in women with epilepsy
@ast
Pharmacogenetic evaluation of ...... c drugs in women with epilepsy
@en
Pharmacogenetic evaluation of ...... c drugs in women with epilepsy
@nl
prefLabel
Pharmacogenetic evaluation of ...... c drugs in women with epilepsy
@ast
Pharmacogenetic evaluation of ...... c drugs in women with epilepsy
@en
Pharmacogenetic evaluation of ...... c drugs in women with epilepsy
@nl
P2093
P2860
P356
P1476
Pharmacogenetic evaluation of ...... c drugs in women with epilepsy
@en
P2093
Anila Mathew
Manna Jose
Moinak Banerjee
Neetha Vijayan
Sanjeev V Thomas
Tashi Bharadwaj
P2860
P304
P356
10.4103/0972-2327.138475
P577
2014-07-01T00:00:00Z